Cargando…

MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation

BACKGROUND: The glioblastoma’s bad prognosis is primarily due to intra-tumor heterogeneity, demonstrated from several studies that collected molecular biology, cytogenetic data and more recently radiomic features for a better prognostic stratification. The GLIFA project (GLIoblastoma Feature Analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiesa, S., Russo, R., Beghella Bartoli, F., Palumbo, I., Sabatino, G., Cannatà, M. C., Gigli, R., Longo, S., Tran, H. E., Boldrini, L., Dinapoli, N., Votta, C., Cusumano, D., Pignotti, F., Lupattelli, M., Camilli, F., Della Pepa, G. M., D’Alessandris, G. Q., Olivi, A., Balducci, M., Colosimo, C., Gambacorta, M. A., Valentini, V., Aristei, C., Gaudino, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892450/
https://www.ncbi.nlm.nih.gov/pubmed/36744131
http://dx.doi.org/10.3389/fmed.2023.1059712
_version_ 1784881325881163776
author Chiesa, S.
Russo, R.
Beghella Bartoli, F.
Palumbo, I.
Sabatino, G.
Cannatà, M. C.
Gigli, R.
Longo, S.
Tran, H. E.
Boldrini, L.
Dinapoli, N.
Votta, C.
Cusumano, D.
Pignotti, F.
Lupattelli, M.
Camilli, F.
Della Pepa, G. M.
D’Alessandris, G. Q.
Olivi, A.
Balducci, M.
Colosimo, C.
Gambacorta, M. A.
Valentini, V.
Aristei, C.
Gaudino, S.
author_facet Chiesa, S.
Russo, R.
Beghella Bartoli, F.
Palumbo, I.
Sabatino, G.
Cannatà, M. C.
Gigli, R.
Longo, S.
Tran, H. E.
Boldrini, L.
Dinapoli, N.
Votta, C.
Cusumano, D.
Pignotti, F.
Lupattelli, M.
Camilli, F.
Della Pepa, G. M.
D’Alessandris, G. Q.
Olivi, A.
Balducci, M.
Colosimo, C.
Gambacorta, M. A.
Valentini, V.
Aristei, C.
Gaudino, S.
author_sort Chiesa, S.
collection PubMed
description BACKGROUND: The glioblastoma’s bad prognosis is primarily due to intra-tumor heterogeneity, demonstrated from several studies that collected molecular biology, cytogenetic data and more recently radiomic features for a better prognostic stratification. The GLIFA project (GLIoblastoma Feature Analysis) is a multicentric project planned to investigate the role of radiomic analysis in GB management, to verify if radiomic features in the tissue around the resection cavity may guide the radiation target volume delineation. MATERIALS AND METHODS: We retrospectively analyze from three centers radiomic features extracted from 90 patients with total or near total resection, who completed the standard adjuvant treatment and for whom we had post-operative images available for features extraction. The Manual segmentation was performed on post gadolinium T1w MRI sequence by 2 radiation oncologists and reviewed by a neuroradiologist, both with at least 10 years of experience. The Regions of interest (ROI) considered for the analysis were: the surgical cavity ± post-surgical residual mass (CTV_cavity); the CTV a margin of 1.5 cm added to CTV_cavity and the volume resulting from subtracting the CTV_cavity from the CTV was defined as CTV_Ring. Radiomic analysis and modeling were conducted in RStudio. Z-score normalization was applied to each radiomic feature. A radiomic model was generated using features extracted from the Ring to perform a binary classification and predict the PFS at 6 months. A 3-fold cross-validation repeated five times was implemented for internal validation of the model. RESULTS: Two-hundred and seventy ROIs were contoured. The proposed radiomic model was given by the best fitting logistic regression model, and included the following 3 features: F_cm_merged.contrast, F_cm_merged.info.corr.2, F_rlm_merged.rlnu. A good agreement between model predicted probabilities and observed outcome probabilities was obtained (p-value of 0.49 by Hosmer and Lemeshow statistical test). The ROC curve of the model reported an AUC of 0.78 (95% CI: 0.68–0.88). CONCLUSION: This is the first hypothesis-generating study which applies a radiomic analysis focusing on healthy tissue ring around the surgical cavity on post-operative MRI. This study provides a preliminary model for a decision support tool for a customization of the radiation target volume in GB patients in order to achieve a margin reduction strategy.
format Online
Article
Text
id pubmed-9892450
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98924502023-02-03 MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation Chiesa, S. Russo, R. Beghella Bartoli, F. Palumbo, I. Sabatino, G. Cannatà, M. C. Gigli, R. Longo, S. Tran, H. E. Boldrini, L. Dinapoli, N. Votta, C. Cusumano, D. Pignotti, F. Lupattelli, M. Camilli, F. Della Pepa, G. M. D’Alessandris, G. Q. Olivi, A. Balducci, M. Colosimo, C. Gambacorta, M. A. Valentini, V. Aristei, C. Gaudino, S. Front Med (Lausanne) Medicine BACKGROUND: The glioblastoma’s bad prognosis is primarily due to intra-tumor heterogeneity, demonstrated from several studies that collected molecular biology, cytogenetic data and more recently radiomic features for a better prognostic stratification. The GLIFA project (GLIoblastoma Feature Analysis) is a multicentric project planned to investigate the role of radiomic analysis in GB management, to verify if radiomic features in the tissue around the resection cavity may guide the radiation target volume delineation. MATERIALS AND METHODS: We retrospectively analyze from three centers radiomic features extracted from 90 patients with total or near total resection, who completed the standard adjuvant treatment and for whom we had post-operative images available for features extraction. The Manual segmentation was performed on post gadolinium T1w MRI sequence by 2 radiation oncologists and reviewed by a neuroradiologist, both with at least 10 years of experience. The Regions of interest (ROI) considered for the analysis were: the surgical cavity ± post-surgical residual mass (CTV_cavity); the CTV a margin of 1.5 cm added to CTV_cavity and the volume resulting from subtracting the CTV_cavity from the CTV was defined as CTV_Ring. Radiomic analysis and modeling were conducted in RStudio. Z-score normalization was applied to each radiomic feature. A radiomic model was generated using features extracted from the Ring to perform a binary classification and predict the PFS at 6 months. A 3-fold cross-validation repeated five times was implemented for internal validation of the model. RESULTS: Two-hundred and seventy ROIs were contoured. The proposed radiomic model was given by the best fitting logistic regression model, and included the following 3 features: F_cm_merged.contrast, F_cm_merged.info.corr.2, F_rlm_merged.rlnu. A good agreement between model predicted probabilities and observed outcome probabilities was obtained (p-value of 0.49 by Hosmer and Lemeshow statistical test). The ROC curve of the model reported an AUC of 0.78 (95% CI: 0.68–0.88). CONCLUSION: This is the first hypothesis-generating study which applies a radiomic analysis focusing on healthy tissue ring around the surgical cavity on post-operative MRI. This study provides a preliminary model for a decision support tool for a customization of the radiation target volume in GB patients in order to achieve a margin reduction strategy. Frontiers Media S.A. 2023-01-19 /pmc/articles/PMC9892450/ /pubmed/36744131 http://dx.doi.org/10.3389/fmed.2023.1059712 Text en Copyright © 2023 Chiesa, Russo, Beghella Bartoli, Palumbo, Sabatino, Cannatà, Gigli, Longo, Tran, Boldrini, Dinapoli, Votta, Cusumano, Pignotti, Lupattelli, Camilli, Della Pepa, D’Alessandris, Olivi, Balducci, Colosimo, Gambacorta, Valentini, Aristei and Gaudino. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chiesa, S.
Russo, R.
Beghella Bartoli, F.
Palumbo, I.
Sabatino, G.
Cannatà, M. C.
Gigli, R.
Longo, S.
Tran, H. E.
Boldrini, L.
Dinapoli, N.
Votta, C.
Cusumano, D.
Pignotti, F.
Lupattelli, M.
Camilli, F.
Della Pepa, G. M.
D’Alessandris, G. Q.
Olivi, A.
Balducci, M.
Colosimo, C.
Gambacorta, M. A.
Valentini, V.
Aristei, C.
Gaudino, S.
MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation
title MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation
title_full MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation
title_fullStr MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation
title_full_unstemmed MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation
title_short MRI-derived radiomics to guide post-operative management of glioblastoma: Implication for personalized radiation treatment volume delineation
title_sort mri-derived radiomics to guide post-operative management of glioblastoma: implication for personalized radiation treatment volume delineation
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892450/
https://www.ncbi.nlm.nih.gov/pubmed/36744131
http://dx.doi.org/10.3389/fmed.2023.1059712
work_keys_str_mv AT chiesas mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT russor mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT beghellabartolif mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT palumboi mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT sabatinog mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT cannatamc mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT giglir mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT longos mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT tranhe mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT boldrinil mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT dinapolin mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT vottac mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT cusumanod mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT pignottif mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT lupattellim mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT camillif mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT dellapepagm mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT dalessandrisgq mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT olivia mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT balduccim mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT colosimoc mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT gambacortama mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT valentiniv mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT aristeic mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation
AT gaudinos mriderivedradiomicstoguidepostoperativemanagementofglioblastomaimplicationforpersonalizedradiationtreatmentvolumedelineation